Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy study of pregabalin in subjects with generalized anxiety disorder
2007-004768-32Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pregabalin in generalized anxiety disorder (GAD) (4 arms), sponsored by Pfizer. Primary endpoints: Efficacy at 3 months, Efficacy at 6 months and 1 more. Started Feb 2008; status: completed.
02
Drugs
pregabalin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2007-004768-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004768-32.